I apologize for being off topic, but just wondered if anyone else here is an owner of HTI (Halozyme Therapeutics).
HTI does not yet have earnings, but they have two approved NDA products. The one to watch is Hylenex, a human recombinant hyaluronidase enzyme. HTI is partnered with Baxter a leading injectable manufacturer. The initial applicaitons for Hylenex are to reduce infusion times in palliative care. But Baxter and HTI are doing Phase 4 studies in a number of other significant areas. These could greatly expand use of the product. Hylenex is not the first enzyme of this type, but previous ones were animal derived and had some safety clouds.
RJ Kirk (CEO New River Pharmaceuticals) and a billionaire has acquired a large position (10%+) in HTI. Kirk previousl started an injectable company so he knows this area.